EDITORIAL FOCUSDetection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular diseaseSerena Viappiani, and Richard SchulzSerena Viappiani, and Richard SchulzPublished Online:01 Jun 2006https://doi.org/10.1152/ajpheart.00128.2006This is the final version - click for previous versionMoreSectionsPDF (40 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat the oxidative modification of proteins is a natural consequence of aerobic life and is also recognized to play a crucial role in the pathological response of cells to increased oxidative stress. Several oxidative modifications of a protein can occur as a result of oxidative stress. These can range from the facile oxidation of cysteine residues to changes caused by higher levels of oxidative stress, resulting in covalent crosslinking with other proteins (whether by S-S linkage or by 2-2′-biphenyl crosslink of 2 tyrosyl radicals), or the formation of noncovalent aggregates or even formation of adducts of proteins with other lipid, carbohydrate, or nucleic acid radicals.Peroxynitrite (ONOO−), the reaction product of nitric oxide and superoxide, is implicated as a key oxidant species in several pathologies and is well known to oxidize proteins. The range of possible modifications begins from the mild oxidation of susceptible cysteine sulfhydryls (resulting in their S-nitrosylation and S-glutathiolation) to what is likely the result of a higher concentration and/or longer duration of exposure to ONOO− to cause direct nitration of tyrosine residues. The nitration of proteins by oxidant species other than ONOO− is also recognized under certain conditions (6). These modifications often result in the alteration of protein function or structure and, usually, inhibition of enzyme function. Proteins containing nitrotyrosine residues have been detected in different pathologies, including diabetes, hypertension, and atherosclerosis, all associated with enhanced oxidative stress, including that caused by increased production of ONOO−.The quest to identify nitrated proteins as a reliable in vivo marker of oxidative stress, particularly to that caused by ONOO−, has proceeded with gusto. Early attempts utilized a polyclonal anti-nitrotyrosine antibody raised originally against nitrated keyhole limpet hemocyanin. In principle, this antibody detects several proteins containing tyrosine residues modified in position 3 of the phenyl ring by a nitro group (3). This antibody is most sensitive in its ability to detect nitrated proteins in situ by immunohistochemistry but has also been used to detect specific nitrated proteins isolated from cells by immunoblotting. Recently, a proteomic approach using this pan-nitrotyrosine antibody showed that a total of 48 putative proteins containing nitrotyrosine were identified in whole heart homogenates of aged rats (8). Two such proteins, a key mitochondrial antioxidant enzyme, Mn2+ superoxide dismutase (MnSOD), or the sarcoplasmic reticulum calcium ATPase type 2 (SERCA2), are nitrated at one or more tyrosine residues in disease states, resulting in a loss of activity. MnSOD is nitrated by ONOO− in its active catalytic site and inactivated by nitration of a single tyrosine, Y-34 (10). SERCA2 has been shown to be nitrated at two adjacent tyrosine residues (Y-294, Y-295) in skeletal and cardiac muscle from aged animals (9, 15), and tyrosine nitration of this enzyme results in decreased activity (1). Because these enzymes regulate critical components of the cell's ability to deal with oxidative stress and calcium handling, it is likely that an inactivation of these enzymes will contribute to the pathogenesis of disease and aging. Indeed, a study in this issue of the American Journal of Physiology-Heart and Circulatory Physiology by Xu et al. (18) shows that both MnSOD and SERCA2 containing nitrotyrosine were found in different pathological conditions, including atherosclerosis, diabetes, and ANG II-induced hypertension, as well as aging.The novelty of the study of Xu et al. (18) relies on the development of antibodies against site-specific nitrotyrosine-modified SERCA2 and MnSOD. Polyclonal and affinity-purified antibodies were raised against two specific tyrosine-nitrated peptides, a 16-amino acid sequence containing nitrated Y-34 of MnSOD and a 20-amino acid peptide containing nitrated Y-294 and Y-295 of SERCA2. Their ability to detect these modified proteins was evaluated by immunohistochemistry. First of all, this study shows that specific nitrotyrosine modifications of these proteins that were only predicted by in vitro studies are confirmed to take place in pathologies involving oxidative stress, not only in animal models but also in human disease. From a cellular point of view, the availability of these antibodies should now be exploited in confocal or immunogold electron microscopy analyses to elucidate the subcellular distribution of such modified proteins. Because posttranslationally modified proteins are characterized not only by different activity but often also by different distribution and rate of degradation, it should now be possible to add new knowledge about the compartmentalization and fate of these oxidized proteins. Indeed, the subtle posttranslational modification of a single amino acid residue of a protein causes a significant increase in its susceptibility to proteolytic degradation (4). For example, when the related cytoplasmic Cu,ZnSOD is exposed to nitrating agents, it becomes nitrated on tyrosine 108 and is consequently degraded by the proteasomal pathway at twice the rate (14). On the other hand, an enzymatic repair mechanism to specifically repair nitrated proteins has also been described (7), suggesting that protein nitration may also be part of a signaling pathway in some cases.The approach taken by Xu et al. (18) showed that nitrated forms of MnSOD and SERCA2 can be readily and specifically identified by immunohistochemical analysis in kidneys of ANG II-infused rats, atherosclerotic rabbit aorta, cardiac sarcoplasmic reticulum and skeletal muscle from aged rats, and blood vessels and atrium obtained from a patient with atherosclerosis and diabetes. Staining was reduced in appropriate controls, including preabsorption with the specific nitrotyrosine-containing peptides or reduction of nitrotyrosine by pretreatment of sections with sodium dithionite to reduce nitrotyrosine to aminotyrosine. These nitrotyrosine-specific peptide-based antibodies will be useful additions to our toolbox for the detection of oxidatively modified proteins, which are supplemented by biochemical and mass spectrometric techniques. A particular advantage is their sensitivity in immunohistochemistry, allowing the detection of their nitrated proteins in small biopsy samples. However, several issues remain, including their lack of sensitivity for use in Western blotting in bulk tissue homogenate (begging the question as to what is the proportion of these nitrated proteins in disease processes), the need for comparison to matched healthy controls in each of the disease models, the subcellular localization of the affected proteins, and whether this has an impact on their distribution compared with the native proteins.Although it is difficult to generalize about posttranslational modifications affecting protein function, reversible reactions (i.e., S-nitrosylation and S-glutathiolation) have more frequently been associated with an increase of enzymatic activity (2). In a very elegant study, Cohen's group (1) previously reported that the activation of SERCA2 is mediated by low micromolar concentrations of ONOO− and glutathione found at a normal concentration within cells. The reversible modification that takes place leads to S-glutathiolation of SERCA2 and results in the increase in Ca2+-ATPase and pump activity, essential for the physiological regulation of vascular tone. However, in pathological conditions such as in the atherosclerotic blood vessel, SERCA2 shows a more severe state of oxidation, mainly due to the irreversible and higher oxidation states of critical cysteine sulfhydryl residues that causes an uncontrolled loss of enzyme activity. Another important class of enzymes activated by ONOO− during mild states of oxidative stress is represented by the family of matrix metalloproteases (MMPs), whose activity has been shown to be increased either by a unique S-O-S-glutathiolation (for MMP-1, -8 and -9) (11) or S-nitrosylation (for MMP-9) (5) of a critical cysteine in the regulatory prodomain of the protein. It appears that an important target of the early phase of ONOO−-induced oxidative stress injury in the heart is activation of MMP-2 and its resultant proteolysis of novel intracellular targets, including troponin I (17) and myosin light chain 1 (13).The findings by Xu et al. (18) support the concept that oxidative stress is an important component in the development of several chronic cardiovascular diseases. To what extent this is a marker or a mediator and how early these alterations occur in the progress of the disease are questions that remain to be answered. If we agree that changes in protein function due to oxidative stress are not merely an index of a disease but a cause of further tissue damage and loss of function, then it is appropriate to plan simple and effective strategies to increase the antioxidant capacity of the human body. This could be achieved simply through regular physical activity and by means of a healthier balanced diet that provides appropriate levels of dietary antioxidants and reduces pathways generating enhanced oxidative stress, such as with the Mediterranean diet and/or supplementation with antioxidants (12, 16).REFERENCES1 Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, and Cohen RA. S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200–1207, 2004.Google Scholar2 Alvarez B and Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25: 295–311, 2003.Crossref | PubMed | ISI | Google Scholar3 Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, and White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375: 81–88, 1994.Crossref | PubMed | ISI | Google Scholar4 Grune T, Reinheckel T, and Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526–534, 1997.Crossref | PubMed | ISI | Google Scholar5 Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, and Lipton SA. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186–1190, 2002.Crossref | PubMed | ISI | Google Scholar6 Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411: 157–160, 1997.Crossref | PubMed | ISI | Google Scholar7 Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, Behbod F, Lee YC, and Murad F. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci USA 95: 11584–11589, 1998.Crossref | PubMed | ISI | Google Scholar8 Kanski J, Behring A, Pelling J, and Schoneich C. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am J Physiol Heart Circ Physiol 288: H371–H381, 2005.Link | ISI | Google Scholar9 Knyushko TV, Sharov VS, Williams TD, Schoneich C, and Bigelow DJ. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry 44: 13071–13081, 2005.Crossref | PubMed | ISI | Google Scholar10 MacMillan-Crow LA, Crow JP, and Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37: 1613–1622, 1998.Crossref | PubMed | ISI | Google Scholar11 Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, and Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276: 29596–29602, 2001.Crossref | PubMed | ISI | Google Scholar12 Powers SK, Quindry J, and Hamilton K. Aging, exercise, and cardioprotection. Ann NY Acad Sci 1019: 462–470, 2004.Crossref | PubMed | ISI | Google Scholar13 Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, and Schulz R. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112: 544–552, 2005.Crossref | PubMed | ISI | Google Scholar14 Smith CD, Carson M, van der Woerd M, Chen J, Ischiropoulos H, and Beckman JS. Crystal structure of peroxynitrite-modified bovine Cu,Zn superoxide dismutase. Arch Biochem Biophys 299: 350–355, 1992.Crossref | PubMed | ISI | Google Scholar15 Viner RI, Ferrington DA, Williams TD, Bigelow DJ, and Schoneich C. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem J 340: 657–669, 1999.Crossref | PubMed | ISI | Google Scholar16 Visioli F, Bogani P, Grande S, and Galli C. Mediterranean food and health: building human evidence. J Physiol Pharmacol 56, Suppl 1: 37–49, 2005.Google Scholar17 Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, and Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106: 1543–1549, 2002.Crossref | PubMed | ISI | Google Scholar18 Xu S, Ying J, Jiang B, Guo W, Adachi T, Sharov V, Lazar H, Menzoian J, Knyushko TV, Bigelow D, Schöneich C, and Cohen RA. Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol 290: H2220–H2227, 2006.Link | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: R. Schulz, Cardiovascular Research Group, Univ. of Alberta, 4–62 HMRC, T6G 2S2 Edmonton, Alberta, Canada (e-mail: [email protected]) Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByRecent advances in the preclinical development of responsive MRI contrast agents capable of detecting hydrogen peroxideJournal of Inorganic Biochemistry, Vol. 230Antioxidants and liver diseasesC3a receptor blockade protects podocytes from injury in diabetic nephropathy12 March 2020 | JCI Insight, Vol. 5, No. 5Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanismsCytokine, Vol. 121Effects of Tetrahydrobiopterin Combined with Nebivolol on Cardiac Diastolic Function in SHRsBiological and Pharmaceutical Bulletin, Vol. 42, No. 7Nebivolol prevents vascular oxidative stress and hypertension in rats chronically treated with ethanolAtherosclerosis, Vol. 274Ethanol withdrawal increases blood pressure and vascular oxidative stress: a role for angiotensin type 1 receptorsJournal of the American Society of Hypertension, Vol. 12, No. 7Oxidative Stress: Noxious but Also Vital9 May 2018Peroxynitrite Footprint in Circulating Neutrophils of Abdominal Aortic Aneurysm Patients is Lower in Statin than in Non-statin UsersEuropean Journal of Vascular and Endovascular Surgery, Vol. 54, No. 3Discovery and identification of potential biomarkers for alcohol-induced oxidative stress based on cellular metabolomics24 January 2017 | Biomedical Chromatography, Vol. 31, No. 7Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca2+-ATPase in diabetic ratsBiochimie, Vol. 127Bladder function in mice with inducible smooth muscle-specific deletion of the manganese superoxide dismutase geneGuiming Liu*, Rania A. Elrashidy*, Nan Xiao, Michael Kavran, Yexiang Huang, Mingfang Tao, C. Thomas Powell, Edward Kim, Ghazal Sadeghi, Hoda E. Mohamed, and Firouz Daneshgari1 August 2015 | American Journal of Physiology-Cell Physiology, Vol. 309, No. 3Pro- and antioxidant systems and pathological processes in humans20 October 2014 | Visnik Nacional'noi' akademii' nauk Ukrai'ni, Vol. 59, No. 10A Mononuclear Manganese(II) Complex Demonstrates a Strategy To Simultaneously Image and Treat Oxidative Stress4 September 2014 | Journal of the American Chemical Society, Vol. 136, No. 37Changes in activity of hippocampus creatine kinase under circadian rhythm disorders17 March 2014 | Biological Rhythm Research, Vol. 58MCP-1and IL-1β expression in the myocardia of two young patients with Type 1 diabetes mellitus and fatal diabetic ketoacidosisExperimental and Molecular Pathology, Vol. 96, No. 1Activation of intracellular matrix metalloproteinase-2 by reactive oxygen–nitrogen species: Consequences and therapeutic strategies in the heartArchives of Biochemistry and Biophysics, Vol. 540, No. 1-2Phosphorylation Status of 72 kDa MMP-2 Determines Its Structure and Activity in Response to Peroxynitrite27 August 2013 | PLoS ONE, Vol. 8, No. 8Investigation of the Mg-HCO 3− -ATPase activity of thyroid tissue cells under various pathologies6 August 2012 | Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, No. 5Angiotensin-(1–7) attenuates diabetic nephropathy in Zucker diabetic fatty ratsJorge F. Giani, Valeria Burghi, Luciana C. Veiras, Analía Tomat, Marina C. Muñoz, Gabriel Cao, Daniel Turyn, Jorge E. Toblli, and Fernando P. Dominici15 June 2012 | American Journal of Physiology-Renal Physiology, Vol. 302, No. 12Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetesCarla Zoja, Sara Cattaneo, Fabio Fiordaliso, Vincenzo Lionetti, Vanessa Zambelli, Monica Salio, Daniela Corna, Chiara Pagani, Daniela Rottoli, Cinzia Bisighini, Giuseppe Remuzzi, and Ariela Benigni1 November 2011 | American Journal of Physiology-Renal Physiology, Vol. 301, No. 5Betulinic acid protects against cerebral ischemia–reperfusion injury in mice by reducing oxidative and nitrosative stressNitric Oxide, Vol. 24, No. 3Proteomics in investigation of protein nitration in kidney disease: Technical challenges and perspectives from the spontaneously hypertensive rat16 December 2010 | Mass Spectrometry Reviews, Vol. 30, No. 1Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice7 July 2010 | Journal of Pharmacology and Experimental Therapeutics, Vol. 335, No. 1Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver26 May 2010 | Journal of Gastroenterology and Hepatology, Vol. 25, No. 6Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems14 September 2009 | Journal of Cellular and Molecular Medicine, Vol. 14, No. 4Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury4 January 2010 | Stem Cells, Vol. 28, No. 3A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitroBiochemical Pharmacology, Vol. 78, No. 8Thoracic Aortic Dissection: Are Matrix Metalloproteinases Involved?1 June 2009 | Vascular, Vol. 17, No. 3Disruption of the Ang II type 1 receptor promotes longevity in miceJournal of Clinical Investigation, Vol. 119, No. 3Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S -nitrosylation of SERCA: role of peroxynitrite29 January 2009 | British Journal of Pharmacology, Vol. 153, No. 3Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modificationBiochemical and Biophysical Research Communications, Vol. 366, No. 4 More from this issue > Volume 290Issue 6June 2006Pages H2167-H2168 Copyright & PermissionsCopyright © 2006 by the American Physiological Societyhttps://doi.org/10.1152/ajpheart.00128.2006PubMed16489112History Published online 1 June 2006 Published in print 1 June 2006 Metrics